TEHRAN, Nov. 17 (MNA) An Iranian knowledge-based company has developed an anticancer drug, SinaDoxosome nanodrug. The medication has reportedly been prescribed for treatment of mammary and ovarian cancers and has also been exported to Russia. Mahnaz Qomi, the directing manager of Exir Nanosina knowledge-based company said that the anticancer doxorubicin ...